Risk factors and clinical outcomes of cytomegalovirus infection following haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia: a single-center retrospective study
Strengthening the monitoring of CMV-DNA in post-transplant patients, actively promoting hematopoietic recovery, preventing the occurrence of CMV infection, and controlling the development of CMV infection can lead to better survival outcomes for patients with aplastic anemia undergoing Haplo-HSCT.
Authors
- Jia Feng
- Dijiong Wu
- Liqiang Wu (ORCID: https://orcid.org/0000-0001-6754-8175)
- Baodong Ye (ORCID: https://orcid.org/0000-0001-5912-2633)
- Qinghong Yu (ORCID: https://orcid.org/0000-0002-7326-7609)
- Junfa Chen
- Yuechao Zhao (ORCID: https://orcid.org/0000-0002-2732-2689)
- Huijin Hu
- Xinhe Zhang (ORCID: https://orcid.org/0000-0002-4325-6079)
- Wenbin Liu (ORCID: https://orcid.org/0000-0001-6837-9756)
- Zhengwei Tan
Institutions
- Zhejiang Chinese Medical University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-01-29
- DOI
- https://doi.org/10.3389/fmed.2024.1523909
- Citations
- 2
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Zhejiang Chinese Medical University